SoCalBio Mast
SoCalBio Weekly Update

 Greetings!  


Cut the Cost of Doing Business 

SoCalBio partners with Office Depot to offer member companies up to 75% off the manufacturer's suggested retail price on a "core list" of office supplies along with aggressive pricing on other catalog items and furniture ...  Learn more 

 

Past Weekly Updates

Thanks to SoCalBio Weekly Update Sponsor 
 
Recommended Events 

Save Money on These Events If You Are a SoCalBio Member

September 16, 2011 
Palo Alto, CA



September 7 - 9

Boston, MA

September 26- 28
Washington DC  

 


October 3-5
Pasadena, CA

 

 

Join SoCalBio
Join SoCalBio leaders to promote the biotech and device industries in the Greater Los Angeles Metro Area for job creation and overall economic growth.
 
When you join, you will enjoy significant discounts on products and services from lab and office supplies to insurance and scientific publications. Discounts are exclusive to SoCalBio member companies in Los Angeles, Orange, Ventura, Santa Barbara, Riverside and San Bernardino counties... Click here to see why
Become a Member
Thanks to SoCalBio Media Partners
August  29, 2011




Editor: Ahmed Enany 
President & CEO
Southern California
Biomedical Council

enany@socalbio.org

www.socalbio.org

Welcome, New SoCalBio Member

WilmerHale

 

With 1000 Lawyers in 12 offices across the US, Asia and Europe, WilmerHale offers legal services to public and private companies, start-up enterprises, partnerships, and entrepreneurial ventures in a wide variety of industrial sectors including the bioscience industry .... Learn more 

 

RSVP Now 

Mergers & Acquisition

Par Pharma to Acquire the Irvine, CA-Based Anchen Pharmaceuticals for $410 Million in Cash

 

Anchen has 218 employees and is focused on developing extended-release and niche generic products, has five commercialized products, 27 abbreviated new drug applications on file with the U.S. Food & Drug Administration, five of which are believed to be first-to-file, and about 26 additional products in development. It expects to launch eight to 10 niche generic products over the next two years ... Read more

 

 Baxter Acquires Ceremed's Bone Wax Product Line

 

Ceremed, Inc. (Los Angeles) announced that it had entered into a definitive agreement to sell its Ostene brand bone hemostasis product line to Baxter International Inc. The agreement provides Baxter with all rights to the Ostene brand, including manufacturing ... Read more

Wound Healing

The Northridge, CA-Based Avita Medical Receives FDA Approval to Initiate Study of Its ReCell Spray-On-Skin for Cosmetic Indications

 

"We are pleased that the FDA has approved our request to study expanded indications for ReCell," said Dr. William Dolphin (photo right), Avita Medical's CEO. "We believe that ReCell offers the potential to deliver significant benefits over currently available options in the treatment of acute and chronic wounds and skin defects. This study will allow us to demonstrate the use of ReCell in the corrective treatment of existing scars with application to the very large cosmetic markets" ... Read more

Drug Approval

BOTOX Receives U.S. FDA Approval for the Treatment of Urinary Incontinence in Adults with Neurological Conditions Including Multiple Sclerosis and Spinal Cord Injury

 

Clinical Trials Showed Approximately 20 Fewer Urinary Leaking Episodes Per Week At Week Six; BOTOX Proven Effective Up To 10 Months In Patients Who Have An Inadequate Response To Or Are Intolerant Of An Anticholinergic Medication "Urinary incontinence due to detrusor overactivity in patients with a neurologic condition is a serious medical problem, and for people who do not respond to or cannot tolerate the side effects of an oral anticholinergic medication, BOTOX is a new long-lasting treatment option to reduce urinary incontinence episodes and address a particularly burdensome issue," said Scott Whitcup, M.D., Allergan'sExecutive Vice President, Research and Development and Chief Scientific Officer. ...  Read more

Device Approval

Ellipse Technologies Announces FDA Clearance to Market the PRECICETM Remote-Control Leg Limb Lengthening Device

 

The Irvine-based Ellipse Technologies announced that it had received FDA marketing clearance of the Company's PRECICE™ Limb Lengthening device in the United States. Limb Lengthening procedures are used to treat a number of medical conditions, including legs shortened due to congenital abnormalities, major fractures of one of the legs and shortened leg bones due to other medical diseases, such as cancer ... Read more

Personnel

Northridge-Based Avita Medical Appoints Senior Researcher Dr. Michael Mendicino to Lead and Expand Its Regenerative Medicine R&D Program

 

Dr. Mendicino will have primary responsibility for the design and conduct of the company's applied research programme in regenerative medicine and tissue engineering. Dr. Mendicino will oversee R&D efforts related to Avita's current regenerative medicine products as well as expansion of the company's product lines ... Read more

Jobs Available

Anchen Pharmaceuticals (Irvine)

Bioness (Valencia)

Alfred Mann Foundation (Valencia)

Biolase (Irvine)

 

Radient Pharmaceuticals (Tustin)

 

Gilead (San Dimas)

About SoCalBio 
 
SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio